Plasma transforming growth factor-β1 level in inflammatory bowel disease

Turkish Journal of Gastroenterology

Volumn 20, Issue 3, 2009, Pages 165-170

  Kiliç, Z Mesut Yalin ^a   Ayaz, Selime ^a   Özin, Yasemin ^a   Nadir, Işilay ^a   Çakal, Başak ^a   Ülker, Aysel ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

Crohn's disease; Inflammatory bowel disease; Transforming growth factor 1; Ulcerative colitis

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BLOOD CELL COUNT; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; REMISSION; SEDIMENTATION RATE; THROMBOCYTE COUNT; ULCERATIVE COLITIS;

ACUTE-PHASE PROTEINS; ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1;

EID: 70350165074     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2009.0002     Document Type: Article

References (29)

1. Wiercinska-Drapalo A, Flisiak R, Prokopowicz D. Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta 1. Cytokine 2001; 14: 343-346 (Pubitemid 32730475)
2. Beck PL, Podolsky DK. Growth factors in inflammatory bowel disease. Inflamm Bowel Dis 1999 Feb; 5: 44-60.
3. Zimmerman CM, Padgett RW. Transforming growth factor beta signaling mediators and modulators. Gene 2000 May 16; 249: 17-30. (Pubitemid 30265484)
4. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994; 106: 533-539 (Pubitemid 24041233)
5. Del Zotto B, Mumolo G, Pronio AM, et al. TGF-beta 1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis. Clin Exp Immunol 2003; 134: 120-6. Erratum in: Clin Exp Immunol 2003 Nov; 134: 365. (Pubitemid 37186597)
6. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342: 1350-1358 (Pubitemid 30408720)
7. Flisiak R, Pytel-Krolczuk B, Prokopowicz D. Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis. Cytokine 2000; 12: 677-681
8. Grainger DJ, Mosedale DE, Metcalfe JC. TGF-beta in blood: a complex problem. Cytokine Growth Factor Rev 2000; 11: 133-145
9. Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996; 110: 975-984 (Pubitemid 26113734)
10. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulfasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989; 298: 82-86 (Pubitemid 19032930)
11. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-444
12. Suemori S, Ciacci C, Podolsky DK. Regulation of transforming growth factor expression in rat intestinal epithelial cell lines. J Clin Invest 1991; 87: 2216-2221
13. Podolsky DK. Peptide growth factors in inflammatory bowel disease: role in mucosal tissue repair. In: Targan SR. Shaman F, eds. Inflammatory bowel disease from bench to bedside. Baltimore: Williams & Wilkins, 1994: 160-170
14. Dignass A, Podolsky DK Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor. Gastroenterology 1993; 105: 1323-1332 (Pubitemid 23315306)
15. Mourelle M, Salas A, Guarner F, et al. Stimulation of transforming growth factor beta-1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis. Gastroenterology 1998; 114: 519-526 (Pubitemid 28141197)
16. Sheng H, Shao J, Hooton EB, et al. Cyclooxygenese-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells. Cell Growth Differ 1997; 8: 463-470 (Pubitemid 27273083)
17. Sambuelli A, Diez RA, Sugai E, et al. Serum transforming growth factor-beta1 levels increase in response to successful anti-inflammatory therapy in ulcerative colitis. Aliment Pharmacol Ther 2000; 14: 1443-1449 (Pubitemid 30944724)
18. Kanazawa S, Tsunoda T, Onuma E, et al . VEGF, basic- FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 2001; 96: 822-828 (Pubitemid 32240738)
19. Fuss IJ, Neurath M, Boirivant M, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157: 1261-1270 (Pubitemid 126449643)
20. Parronchi P, Romagnani P, Annunziato F, et al. Type 1 T-helper cell predominance and IL-12 expression in the gut of patients with Crohn's's disease. Am J Pathol 1997; 150: 823-832 (Pubitemid 27106154)
21. Seder RA, Marth T, Sieve MC, et al. Factors involved in the differentiation of TGF-b-producing cells from naive CD4+ T cells: IL-4 and IFN-γ have opposing effects, while TGF-b positively regulates its own production. J Immunol 1998; 160: 5719-5728 (Pubitemid 28298027)
22. Parrelli JM, Meisler N, Cutroneo KR. Identification of a glucocorticoid response element in the human transforming growth factor beta 1 gene promoter. Int J Biochem Cell Biol 1998; 30: 623-627 (Pubitemid 28302739)
23. Khanna AK, Cairns VR, Becker CG, et al. Transforming growth factor (TGF)-beta mimics and anti-TGF-beta antibody abrogates the in vivo effects of cyclosporine: demonstration of a direct role of TGF-beta in immunosuppression and nephrotoxicity of cyclosporine. Transplantation 1999; 67: 882-889
24. Moran A, Jones A, Asquith P Laboratory markers of colonoscopic activity in ulcerative colitis and Crohn's colitis. Scand J Gastroenterol 1995; 30: 356-360
25. Niederau C, Backmerhoff F, Schumacher B, et al. Inflammatory mediators and acute phase proteins in patients with Crohn's's disease and ulcerative colitis. Hepato-Gastroenterol 1997; 44: 90-107. (Pubitemid 27096020)
26. Bitton A, Peppercorn MA, Antonioli DA, et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterol 2001; 120: 13-20. (Pubitemid 32061864)
27. Rodgers AD, Cummins AG. CRP correlates with clinical score in ulcerative colitis but not in Crohn's disease. Dig Dis Sci 2007; 52: 2063-2068 Epub 2007 Apr 11.
28. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 2006 Mar; 55: 426-431
29. Gisbert JP, González-Lama Y, Maté J. Role of biological markers in inflammatory bowel disease. Gastroenterol Hepatol 2007; 30: 117-129 (Pubitemid 46682851)